Affinity Asset Advisors, LLC has filed its 13F form on November 13, 2025 for Q3 2025 where it was disclosed a total value porftolio of $862 Million distributed in 96 stocks.

Among their holdings, we can observe that their the top five positions include companies like: Verona Pharma PLC with a value of $66.7M, Insmed Inc with a value of $64.8M, Spdr S&P 500 ETF Trust with a value of $56.3M, Xenon Pharmaceuticals Inc. with a value of $56.2M, and Madrigal Pharmaceuticals, Inc. with a value of $52.7M.

Examining the 13F form we can see an increase of $266M in the current position value, from $596M to 862M.

Affinity Asset Advisors, LLC is based out at New York, NY

Below you can find more details about Affinity Asset Advisors, LLC portfolio as well as his latest detailed transactions.

Portfolio value $862 Million
Healthcare: $805 Million
ETFs: $56.3 Million

Stock Holdings Table

Stock Market Cap. Holding Value (Reported) # of Shares. Last Trade Trade History

Summary

  • Portfolio
  • No. of Stocks 96
  • Current Value $862 Million
  • Prior Value $596 Million
  • Filing
  • Period Q3 2025
  • Filing Date November 13, 2025
  • Form Type 13F-HR
  • Activity in Q3 2025
  • New Purchases 22 stocks
  • Additional Purchases 26 stocks
  • Sold out of 0 stocks
  • Reduced holdings in 17 stocks
Track This Portfolio

Track Affinity Asset Advisors, LLC Portfolio

Follow Affinity Asset Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Affinity Asset Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Affinity Asset Advisors, LLC with notifications on news.